Mimedx (MDXG) Gross Margin (2011 - 2026)
Mimedx recorded quarterly Gross Margin of 70.56% in Q1 2026, down 15.87% quarter-over-quarter from 83.86% in Q4 2025, and down 1067.0% year-over-year from 7.3% in Q1 2025.
Mimedx's Gross Margin history runs 16 years deep, the most recent figure standing at 70.56% for Q1 2026.
- In Q1 2026, Gross Margin fell 1067.0% year-over-year to 70.56%; the TTM figure through Mar 2026 stood at 81.04% (down 90.0% YoY), while the FY2025 annual figure was 82.56%, down 22.0% from the prior year.
- Gross Margin came in at 70.56% for Q1 2026 at Mimedx, down from 83.86% in the prior quarter.
- In the past five years, Gross Margin ranged from a high of 84.67% in Q1 2024 to a low of 70.56% in Q1 2026.
- A 5-year average of 81.85% and a median of 82.32% in 2022 frame the typical range for Gross Margin.
- Across the five-year window, Gross Margin surged 338 bps in 2023 and slumped 1067 bps in 2026, its largest moves.
- Mimedx's Gross Margin stood at 80.68% in 2022, then increased by 4 bps to 84.06% in 2023, then slipped by 3 bps to 81.8% in 2024, then increased by 3 bps to 83.86% in 2025, then declined by 16 bps to 70.56% in 2026.
- According to Business Quant data, Gross Margin over the past three periods registered 70.56%, 83.86%, and 83.54% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 79.04% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 86.85% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 91.79% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 82.22% |
| 10 | Mimedx | 530.69 Mn | 370.92 Mn | 41.62 Mn | 70.56% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 70.56% |
| Dec 31, 2025 | 83.86% |
| Sep 30, 2025 | 83.54% |
| Jun 30, 2025 | 81.05% |
| Mar 31, 2025 | 81.23% |
| Dec 31, 2024 | 81.80% |
| Sep 30, 2024 | 81.77% |
| Jun 30, 2024 | 82.97% |
| Mar 31, 2024 | 84.67% |
| Dec 31, 2023 | 84.06% |
| Sep 30, 2023 | 81.90% |
| Jun 30, 2023 | 83.28% |
| Mar 31, 2023 | 82.67% |
| Dec 31, 2022 | 80.68% |
| Sep 30, 2022 | 81.99% |
| Jun 30, 2022 | 82.32% |
| Mar 31, 2022 | 83.13% |
| Dec 31, 2021 | 86.03% |
| Sep 30, 2021 | 83.94% |
| Jun 30, 2021 | 81.28% |
| Mar 31, 2021 | 83.92% |
| Dec 31, 2020 | 84.22% |
| Sep 30, 2020 | 84.00% |
| Jun 30, 2020 | 84.72% |
| Mar 31, 2020 | 83.76% |
| Dec 31, 2019 | 83.37% |
| Sep 30, 2019 | 85.14% |
| Jun 30, 2019 | 85.54% |
| Mar 31, 2019 | 88.85% |
| Dec 31, 2018 | 88.76% |
| Sep 30, 2018 | 91.54% |
| Jun 30, 2018 | 90.28% |
| Mar 31, 2018 | 88.88% |
| Dec 31, 2017 | 89.30% |
| Sep 30, 2017 | 88.93% |
| Jun 30, 2017 | 89.46% |
| Mar 31, 2017 | 88.33% |
| Dec 31, 2016 | 87.02% |
| Sep 30, 2016 | 87.59% |
| Jun 30, 2016 | 87.11% |
| Mar 31, 2016 | 85.11% |
| Dec 31, 2015 | 90.38% |
| Sep 30, 2015 | 89.84% |
| Jun 30, 2015 | 88.86% |
| Mar 31, 2015 | 87.37% |
| Dec 31, 2014 | 90.90% |
| Sep 30, 2014 | 90.01% |
| Jun 30, 2014 | 89.29% |
| Mar 31, 2014 | 84.78% |
| Dec 31, 2013 | 82.71% |
| Sep 30, 2013 | 86.88% |
| Jun 30, 2013 | 83.73% |
| Mar 31, 2013 | 83.52% |
| Dec 31, 2012 | 83.93% |
| Sep 30, 2012 | 82.08% |
| Jun 30, 2012 | 77.17% |
| Mar 31, 2012 | 74.12% |
| Dec 31, 2011 | 65.23% |
| Sep 30, 2011 | 58.81% |
| Jun 30, 2011 | 56.21% |
| Mar 31, 2011 | 31.95% |